Evidence map›Paper›PMID 41594603›Full record

ReviewBiomolecules2025

Xia Yang, Fang Dou, Lang Hai, Yating Xiao, Jie Cui, Yangyang Cai, Rui Wang, Kai Ji, Yalong Feng, Hua Chen

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xia YangKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Fang DouSchool of Medical Care, Sichuan Vocational and Technical College, No. 1 Xuefu North Road, Suining 629000, China.
Lang HaiKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Yating XiaoKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Jie CuiKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Yangyang CaiKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Rui WangKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Kai JiKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Yalong FengSchool of Chemistry and Chemical Engineering, Xianyang Normal University, Xianyang 712000, China.
Hua ChenKey Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.ORCID 0000-0001-5564-4610

Funding

Key R&D Plan Project of Ningxia 2024BEG01006, 2021BEB04080National Natural Science Foundation of China 82460731, 82003836Research Project of Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University KFKT202313
6 · The paper itself

Abstract

The incidence of kidney diseases has been increasing due to changes in modern lifestyles and the ecological environment. The progression of kidney disease is characterized by ongoing renal damage and a gradual decline in renal function, ultimately leading to end-stage renal disease. The limitations of present medications have brought many disadvantages to patients. Consequently, identifying bioactive molecules has emerged as a critical strategy in the development of novel therapies for kidney diseases, particularly those derived from natural medicinal resources. This review presents a comprehensive analysis of renoprotective effects and underlying mechanisms of the medicinal plant

Indexed as

Kidney DiseasesPlant ExtractsScutellaria baicalensisAnimalsFlavanonesFlavonoidsHumansOxidative StressbaicaleinbaicalinFlavanonesFlavonoidsPlant Extractsacute kidney injurychronic kidney diseaseflavonoidsradix scutellariaeScutellaria baicalensis Georgi

Identifiers

PMID41594603
PMCPMC12838776

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.